Current Obstetrics and Gynecology Reports This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology
This article discusses the role of complementary and alternative medicine (CAM) in the management of fibroids and associated symptomatology. Since there is such a paucity of direct research related to fibroids, conditions that are implicated in the causation of uterine fibroids and symptomatology that CAM treatments may or have been shown to make a difference are also considered. (Source: Current Obstetrics and Gynecology Reports)
Source: Current Obstetrics and Gynecology Reports - April 24, 2016 Category: OBGYN Source Type: research

Fibroids and Infertility
This article examines the mechanisms by which fibroids affect implantation and fertility, and stratifies their impact on basis of size, location and nature. It also explores the evidence base of the available treatment modalities in specific relation to improving fertility outcomes. Traditionally, a myomectomy has been advocated to treat fibroids for the reproductive population; however, as well as evaluating the benefits of surgery including endoscopic, this article explores alternative therapies including medical and radiological interventions. (Source: Current Obstetrics and Gynecology Reports)
Source: Current Obstetrics and Gynecology Reports - April 24, 2016 Category: OBGYN Source Type: research

Endoscopic Treatment and Power Morcellation of Uterine Fibroids
Abstract Although a variety of pharmacological and radiological treatment options are available, surgery in the form of myomectomy or hysterectomy provides a quick and effective relief of many symptoms, albeit with attendant surgical risks. In this article, we discuss endoscopic surgical treatments, their relative benefits, and their risks, including risk of morcellation. Patient selection and preoperative preparation for various surgical approaches is discussed. Overall, the evidence base for surgical treatments, including endoscopic, is weak, and, therefore, a pragmatic approach is outlined. (Source: Cu...
Source: Current Obstetrics and Gynecology Reports - April 11, 2016 Category: OBGYN Source Type: research

Quality Measures for Prolapse Management
Abstract Quality measure development has become increasingly important over the past few years, and there have been many attempts to increase the scientific literature on the subject. Measurement of quality is now an integral part of the healthcare system. This review considers recently recommended quality metrics for prolapse management, subdividing these into structural, process, and outcome metrics. The Quality in Prolapse Surgery (QuIPS) project, Choosing Wisely® campaign by the American Board of Internal Medicine (ABIM), quality measures proposed by AUGS, and the 2012 joint report from IUGA and Inte...
Source: Current Obstetrics and Gynecology Reports - April 11, 2016 Category: OBGYN Source Type: research

Concomitant Incontinence Surgery at the Time of Prolapse Repair
Abstract Pelvic organ prolapse and stress urinary incontinence are two very common pelvic floor complaints in women. Many women choose definitive surgical treatment for bothersome prolapse; the number of women choosing this treatment option is projected to increase significantly by 2050. The literature is mixed in regards to management of occult stress urinary incontinence in patients undergoing prolapse repair. Various approaches to evaluation of occult stress urinary incontinence with prolapse reduction will be reviewed such as the universal, selective, and staged approaches. Informed consent that inclu...
Source: Current Obstetrics and Gynecology Reports - April 10, 2016 Category: OBGYN Source Type: research

Nonsurgical vs. Surgical Treatment Options for Pelvic Organ Prolapse: Review of the Current Evidence
The objective of this article is to review the available evidence comparing nonsurgical and surgical options for pelvic organ prolapse. (Source: Current Obstetrics and Gynecology Reports)
Source: Current Obstetrics and Gynecology Reports - April 6, 2016 Category: OBGYN Source Type: research

Uterine Fibroid Mapping
This article reviews the full spectrum of modalities in common use today to help achieve this goal, outlines their relative effectiveness, and provides an expert insight where applicable. (Source: Current Obstetrics and Gynecology Reports)
Source: Current Obstetrics and Gynecology Reports - April 6, 2016 Category: OBGYN Source Type: research

The Effect of Pelvic Organ Prolapse Surgery on Pre-existing Overactive Bladder
Abstract Overactive bladder (OAB) and pelvic organ prolapse (POP) are both significant and debilitating conditions for many women. They often coexist but a causal relationship is not known. Surgical repair of POP has been found to improve OAB symptoms to varying degrees. Some studies have examined possible factors associated with OAB improvement after surgery for POP such as exam findings, symptoms, and urodynamic parameters, but none have been robustly shown to predict outcomes. When counseling patients regarding expectations after prolapse correction surgery, it is important to appreciate that it cannot...
Source: Current Obstetrics and Gynecology Reports - March 31, 2016 Category: OBGYN Source Type: research

An Overview of the Aetiology, Epidemiology, Symptomatology and Management of Uterine Fibroids
Abstract Uterine fibroids are the most common benign tumour to affect women and although many are asymptomatic, those that do cause symptoms often do so with significant morbidity. Whilst historically the mainstay of treatment was abdominal hysterectomy, evolving medical and surgical techniques have facilitated new and often more conservative management options. For those wishing to avoid operative intervention, there are now several medical therapies effective in alleviating the symptoms of fibroids, in some cases reducing their size. Improved access to laparoscopic surgery, along with advances in radiol...
Source: Current Obstetrics and Gynecology Reports - March 31, 2016 Category: OBGYN Source Type: research

Current Trends in Management of Defecatory Dysfunction, Posterior Compartment Prolapse, and Fecal Incontinence
Abstract While it would be our hope to report that there have been significant gains in the understanding of the correlation between the posterior vaginal compartment and defecatory dysfunction in the last year, this is not the case. Instead, we review the highlights of management of posterior vaginal compartment and defecatory dysfunction including (1) defining and understanding the patient’s symptoms; (2) considering systemic disorders, motility dysfunction, and mechanical causes that may be contributing; (3) encouraging conservative management as first-line therapy; and (4) recognizing which surgical...
Source: Current Obstetrics and Gynecology Reports - March 31, 2016 Category: OBGYN Source Type: research

Uterine Conservation at the Time of Pelvic Organ Prolapse Treatment: the Options for Patients and Providers
This article will review the historical perspective of uterine conservation, patient selection, conservative management, as well as surgical techniques and recent supporting literature of uterine-sparing procedures for POP. As women seek more minimally invasive approaches for prolapse repair, we anticipate that uterine conservation will continue to gain popularity. (Source: Current Obstetrics and Gynecology Reports)
Source: Current Obstetrics and Gynecology Reports - March 30, 2016 Category: OBGYN Source Type: research

Native Tissue Surgery for Prolapse versus Graft/Mesh Use: Current Trends in Reconstructive Surgery
Abstract Pelvic organ prolapse, characterized by a descent of the vaginal walls or vaginal apex, can be treated surgically in symptomatic women who decline or have failed conservative management. Because prolapse can recur after surgery, mesh and biologic grafts have been developed to augment repairs. Use of transvaginal mesh materials quickly increased in the early twenty-first century; however, since the FDA warnings about potential serious complications from transvaginal mesh in 2008 and 2011, use has decreased dramatically, and many mesh products were removed from the market. Even through the peak of ...
Source: Current Obstetrics and Gynecology Reports - March 30, 2016 Category: OBGYN Source Type: research

Office Hysteroscopic Treatment of Uterine Fibroids
Abstract Advances in endoscopic and therapeutic hysteroscopic technology have made the removal of submucosal fibroids possible in the outpatient setting. Removal of submucosal fibroids can be particularly challenging in the outpatients due to intramural components of some submucosal fibroids and the hard consistency of fibroids which makes specimen retrieval rather difficult through the endocervical canal. Fibroids which are <2 cm and completely intracavitary are easier to remove in the outpatients. Specimen retrieval can be addressed either by slicing the fibroid using bipolar electrodes, by using a ...
Source: Current Obstetrics and Gynecology Reports - March 29, 2016 Category: OBGYN Source Type: research

Epidemiology of Pelvic Organ Prolapse
Abstract Understanding and applying the epidemiology of pelvic organ prolapse (POP) is necessary to provide quality patient care to a growing and aging female population. As the elderly population is expected to almost double from 2012 to 2050, POP will become more prevalent, placing greater demands on our health care system and specialty-trained providers. In this review, we will evaluate and summarize recent literature and also highlight older studies of clinical significance that contribute to an overall understanding of the topic. While prevalence rates vary, the proportion of women with bothersome PO...
Source: Current Obstetrics and Gynecology Reports - March 29, 2016 Category: OBGYN Source Type: research

An Update on the Use of Mesh in Pelvic Reconstructive Surgery
Abstract By 2008, the use of vaginal mesh in gynecologic surgery was at its peak. Unfortunately, the rise in transvaginal mesh use was accompanied by a significant rise in mesh-related complications. Over the last 5 years, the FDA has been very proactive in regulating the use of transvaginal mesh, and its use has declined substantially since FDA sanctions were placed. Mesh for the treatment of stress urinary incontinence and transabdominal repair of pelvic organ prolapse is still supported by the FDA as well as the gynecologic and urologic societies. Surgeons should exercise caution when using any type o...
Source: Current Obstetrics and Gynecology Reports - March 27, 2016 Category: OBGYN Source Type: research